DK0583271T3 - Arylmorpholin, fremstilling og anvendelse - Google Patents

Arylmorpholin, fremstilling og anvendelse

Info

Publication number
DK0583271T3
DK0583271T3 DK92908819T DK92908819T DK0583271T3 DK 0583271 T3 DK0583271 T3 DK 0583271T3 DK 92908819 T DK92908819 T DK 92908819T DK 92908819 T DK92908819 T DK 92908819T DK 0583271 T3 DK0583271 T3 DK 0583271T3
Authority
DK
Denmark
Prior art keywords
manufacture
human
aryl morpholine
morpholine
aryl
Prior art date
Application number
DK92908819T
Other languages
Danish (da)
English (en)
Inventor
James Leroy Kelley
Nariman Bomanshaw Mehta
Grady Evan Boswell
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0583271T3 publication Critical patent/DK0583271T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92908819T 1991-04-23 1992-04-22 Arylmorpholin, fremstilling og anvendelse DK0583271T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919108629A GB9108629D0 (en) 1991-04-23 1991-04-23 Heterocyclic pharmaceutical compounds,preparation and use
PCT/GB1992/000733 WO1992018489A1 (en) 1991-04-23 1992-04-22 Arylmorpholine, preparation and use

Publications (1)

Publication Number Publication Date
DK0583271T3 true DK0583271T3 (da) 1999-07-26

Family

ID=10693740

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92908819T DK0583271T3 (da) 1991-04-23 1992-04-22 Arylmorpholin, fremstilling og anvendelse

Country Status (17)

Country Link
US (2) US5648347A (de)
EP (1) EP0583271B1 (de)
JP (1) JP3130040B2 (de)
AT (1) ATE173252T1 (de)
AU (1) AU668863B2 (de)
CA (1) CA2108967C (de)
DE (1) DE69227583T2 (de)
DK (1) DK0583271T3 (de)
ES (1) ES2124256T3 (de)
FI (1) FI934680A0 (de)
GB (1) GB9108629D0 (de)
HU (1) HU219458B (de)
IE (1) IE921260A1 (de)
NZ (1) NZ242421A (de)
PT (1) PT100415B (de)
WO (1) WO1992018489A1 (de)
ZA (1) ZA922910B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
SK10912000A3 (sk) 1998-01-21 2001-04-09 Glaxo Group Limited Farmaceuticky prijateľné soli a solváty (+)-(2s,3s)-2-(3-chlórfenyl)-3,5,5-trimetyl-2-morfolinolu, farmaceutický prostriedok s ich obsahom a ich použitie
US7098206B2 (en) * 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) * 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
FR2796069B3 (fr) * 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
GB0228787D0 (en) * 2002-12-10 2003-01-15 Pfizer Ltd Morpholine dopamine agonists
US7323462B2 (en) 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
ES2339767T3 (es) * 2002-12-10 2010-05-25 Pfizer Inc. Derivados de morfolina para usar como agonistas de dopamina en el tratamiento de la disfuncion sexual entre otros.
WO2011146850A1 (en) 2010-05-21 2011-11-24 Research Triangle Institute Phenylmorpholines and analogues thereof
EP2571859B1 (de) 2010-05-21 2015-07-22 Research Triangle Institute 1-phenylmorpholine-derivative als hydroxybupropion analogen bei der behandlung von drogenabhängigkeit
CN105949142B (zh) * 2016-05-21 2018-03-27 南华大学 具有抗抑郁活性的单一手性化合物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997469A (en) * 1961-08-22 Preparation of substituted
GB851311A (en) * 1958-04-02 1960-10-12 Geigy Ag J R Morpholine compounds and their production
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
GB1336732A (en) * 1970-10-28 1973-11-07 Istituto Gentili Spa Pisa Diethanolamine derivatives
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
FR2517305B1 (fr) * 1981-12-01 1985-10-25 Lafon Labor Nouveaux derives de 2-phenyl-morpholine et leur utilisation en therapeutique
FR2553410B1 (fr) * 1983-10-14 1986-05-16 Lafon Labor Nouveaux derives de 2-tolyl-morpholine utiles en therapeutique
FR2553411B1 (fr) * 1983-10-14 1986-08-01 Lafon Labor Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8417170D0 (en) * 1984-07-05 1984-08-08 Wellcome Found Heterocyclic pharmaceutical compounds
US4803200A (en) * 1987-10-02 1989-02-07 A. H. Robins Company, Incorporated Substituted dialkanolamines, sulfur analogs and condensed 1,4-oxazine derivatives thereof in viral disease treatment
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use

Also Published As

Publication number Publication date
CA2108967C (en) 2002-10-08
JPH06506675A (ja) 1994-07-28
FI934680A (fi) 1993-10-22
IE921260A1 (en) 1992-11-04
WO1992018489A1 (en) 1992-10-29
GB9108629D0 (en) 1991-06-12
CA2108967A1 (en) 1992-10-24
JP3130040B2 (ja) 2001-01-31
PT100415A (pt) 1993-06-30
FI934680A0 (fi) 1993-10-22
EP0583271B1 (de) 1998-11-11
DE69227583T2 (de) 1999-04-01
HU219458B (hu) 2001-04-28
PT100415B (pt) 1999-08-31
ATE173252T1 (de) 1998-11-15
HU9303000D0 (en) 1994-01-28
US5760224A (en) 1998-06-02
EP0583271A1 (de) 1994-02-23
AU668863B2 (en) 1996-05-23
ES2124256T3 (es) 1999-02-01
DE69227583D1 (de) 1998-12-17
HUT70531A (en) 1995-10-30
AU1575392A (en) 1992-11-17
US5648347A (en) 1997-07-15
ZA922910B (en) 1994-01-24
NZ242421A (en) 1994-10-26

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
SE9604786D0 (sv) New compounds
DK0583271T3 (da) Arylmorpholin, fremstilling og anvendelse
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
HUP0300615A2 (hu) Sibutramint és orlistatot tartalmazó gyógyszerkészítmény
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
SE9504662D0 (sv) New compounds
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
ES2104938T3 (es) Metodo de inhibir la fibrosis.
MY133438A (en) Morpholinobenzamide salts
DK0769945T3 (da) Brug af 2-phenyl-3-aroylbenzothiophenderivater til fremstilling af et medikament til behandling af knogler og knoglebrud
SE9603284D0 (sv) New compounds
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
DK0772438T3 (da) Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
ATE56445T1 (de) Pharmacologisch aktive propionylanilide.
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.